This Stock Could Soar by 120%, According to Wall Street
Don't rush to buy shares just yet.
Source: fool.com
Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Don't rush to buy shares just yet.
The popular growth investor keeps adding to some of her favorite stocks.
Cathie Wood just gave the company a huge vote of confidence.
The acceleration of Genentech’s machine learning (ML) capabilities will take place on Nvidia’s DGX Cloud. This includes Nvidia BioNemo, which uses generative AI applications in drug discovery.
In a notable insider transaction, Shafique Virani, the Chief Business Officer of Recursion Pharmaceuticals Inc (NASDAQ:RXRX), sold 18,000 shares of the company on November 15, 2023.